FI62052C - Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan - Google Patents

Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan Download PDF

Info

Publication number
FI62052C
FI62052C FI3770/73A FI377073A FI62052C FI 62052 C FI62052 C FI 62052C FI 3770/73 A FI3770/73 A FI 3770/73A FI 377073 A FI377073 A FI 377073A FI 62052 C FI62052 C FI 62052C
Authority
FI
Finland
Prior art keywords
amino
phenyl
ethanol
melting point
tert
Prior art date
Application number
FI3770/73A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI62052B (fi
Inventor
Guenther Engelhardt
Johannes Keck
Gerd Krueger
Klaus-Reinhold Noll
Helmut Pieper
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2261914A external-priority patent/DE2261914C3/de
Priority claimed from DE19732345442 external-priority patent/DE2345442C2/de
Priority claimed from DE19732351281 external-priority patent/DE2351281C3/de
Priority claimed from DE2354961A external-priority patent/DE2354961C2/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Priority to FI812795A priority Critical patent/FI69837C/fi
Publication of FI62052B publication Critical patent/FI62052B/fi
Application granted granted Critical
Publication of FI62052C publication Critical patent/FI62052C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/28—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C215/30—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings containing hydroxy groups and carbon atoms of six-membered aromatic rings bound to the same carbon atom of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/04—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
FI3770/73A 1972-12-18 1973-12-10 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan FI62052C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI812795A FI69837C (fi) 1972-12-18 1981-09-08 Foerfarande foer framstaellning av farmakologiskt vaerdeful 4-mino-fenyloxazolidin och dess syraadditionssalter

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE2261914A DE2261914C3 (de) 1972-12-18 1972-12-18 Amino-phenyl-äthanolamine und deren Säureadditionssalze, Verfahren zu deren Herstellung und Arzneimittel
DE2261914 1972-12-18
DE2345442 1973-09-08
DE19732345442 DE2345442C2 (de) 1973-09-08 1973-09-08 d- und l-Phenyläthanolamine und deren Salze, Herstellungsverfahren und Arzneimittel auf deren Basis
DE2351281 1973-10-12
DE19732351281 DE2351281C3 (de) 1973-10-12 1973-10-12 Aminophenyl-äthanolamin-Derivate, deren Herstellung und Verwendung
DE2354961 1973-11-02
DE2354961A DE2354961C2 (de) 1973-11-02 1973-11-02 Verfahren zur Herstellung von Aminophenyl-äthanolaminen

Publications (2)

Publication Number Publication Date
FI62052B FI62052B (fi) 1982-07-30
FI62052C true FI62052C (fi) 1982-11-10

Family

ID=27431596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI3770/73A FI62052C (fi) 1972-12-18 1973-12-10 Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan

Country Status (20)

Country Link
JP (1) JPS5811852B2 (enrdf_load_stackoverflow)
KR (1) KR850001916B1 (enrdf_load_stackoverflow)
BG (1) BG21209A3 (enrdf_load_stackoverflow)
CA (1) CA1027955A (enrdf_load_stackoverflow)
CH (2) CH605622A5 (enrdf_load_stackoverflow)
DD (1) DD111574A5 (enrdf_load_stackoverflow)
DK (1) DK150502C (enrdf_load_stackoverflow)
FI (1) FI62052C (enrdf_load_stackoverflow)
FR (1) FR2210414B1 (enrdf_load_stackoverflow)
GB (1) GB1445740A (enrdf_load_stackoverflow)
HK (1) HK6680A (enrdf_load_stackoverflow)
HU (1) HU168701B (enrdf_load_stackoverflow)
IE (1) IE39065B1 (enrdf_load_stackoverflow)
IL (1) IL43837A (enrdf_load_stackoverflow)
MY (1) MY8800145A (enrdf_load_stackoverflow)
NL (1) NL176168C (enrdf_load_stackoverflow)
NO (1) NO137782C (enrdf_load_stackoverflow)
PL (1) PL97194B1 (enrdf_load_stackoverflow)
RO (1) RO63025A (enrdf_load_stackoverflow)
SE (1) SE409700B (enrdf_load_stackoverflow)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430486A1 (fr) * 1978-07-07 1980-02-01 Oreal Conditionnement d'un produit desinfectant et desodorisant pour cuvette de toilettes
NL8105170A (nl) * 1980-12-10 1982-07-01 Thomae Gmbh Dr K Nieuwe fenylalkylaminen, werkwijze ter bereiding daarvan en de toepassing daarvan als geneesmiddelen.
FR2515177A1 (fr) * 1981-10-28 1983-04-29 Lafon Labor Nouveaux derives de 1-(aminophenyl)-2-amino-1-ethanol, leur procede de preparation et leur utilisation en therapeutique
GB8426191D0 (en) * 1984-10-17 1984-11-21 Glaxo Holdings Ltd Chemical compounds
US4943591A (en) * 1984-10-17 1990-07-24 Glaxo Group Limited Dichloroaniline derivatives
US4863959A (en) * 1985-10-17 1989-09-05 American Cyanamid Company Anthranilonitrile derivatives as useful agents for promoting growth, improving feed efficiency, and for increasing the lean meat to fat ratio of warm-blooded animals
ES2021267B3 (es) * 1985-10-17 1991-11-01 American Cyanamid Co Metodo para promover el crecimiento, mejorar la eficacia alimenticia y para acelerar el engorde en animales de sangre caliente.
GB8603475D0 (en) * 1986-02-12 1986-03-19 Glaxo Group Ltd Chemical compounds
GB8703007D0 (en) * 1987-02-10 1987-03-18 Glaxo Group Ltd Chemical compounds
EP0278727A3 (en) * 1987-02-10 1990-03-14 Glaxo Group Limited 1-(4-amino-3-chloro-5-trifluoromethylphenyl)-2-(substituted amino)ethanol derivatives and their use in the treatment of respiratory disease
CA2537124C (en) * 2003-08-29 2012-08-07 Mitsui Chemicals, Inc. Agricultural/horticultural insecticide and method for using the same
GB0604822D0 (en) * 2006-03-09 2006-04-19 Arakis Ltd The treatment of inflammatory disorders and pain
CN100497296C (zh) * 2006-07-07 2009-06-10 沈阳药科大学 旋光活性的苯乙醇胺类化合物及其制法
GB201714745D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714736D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201714734D0 (en) 2017-09-13 2017-10-25 Atrogi Ab New compounds and uses
GB201903832D0 (en) 2019-03-20 2019-05-01 Atrogi Ab New compounds and methods

Also Published As

Publication number Publication date
HK6680A (en) 1980-03-07
FI62052B (fi) 1982-07-30
HU168701B (enrdf_load_stackoverflow) 1976-06-28
CH605622A5 (enrdf_load_stackoverflow) 1978-10-13
PL97194B1 (pl) 1978-02-28
MY8800145A (en) 1988-12-31
CH614188A5 (en) 1979-11-15
NL176168B (nl) 1984-10-01
BG21209A3 (bg) 1976-03-20
IE39065B1 (en) 1978-08-02
NO137782B (no) 1978-01-16
SE409700B (sv) 1979-09-03
GB1445740A (en) 1976-08-11
JPS5811852B2 (ja) 1983-03-04
KR830000207A (ko) 1983-03-30
JPS4994640A (enrdf_load_stackoverflow) 1974-09-09
DK150502B (da) 1987-03-16
FR2210414B1 (enrdf_load_stackoverflow) 1977-01-28
NL7316139A (enrdf_load_stackoverflow) 1974-06-20
IL43837A0 (en) 1974-03-14
AU6369373A (en) 1975-06-19
RO63025A (fr) 1978-12-15
CA1027955A (en) 1978-03-14
FR2210414A1 (enrdf_load_stackoverflow) 1974-07-12
KR850001916B1 (ko) 1985-12-31
DK150502C (da) 1987-10-26
IE39065L (en) 1974-06-18
DD111574A5 (enrdf_load_stackoverflow) 1975-02-20
IL43837A (en) 1977-02-28
NO137782C (no) 1978-04-26
NL176168C (nl) 1985-03-01

Similar Documents

Publication Publication Date Title
FI62052C (fi) Foerfarande foer framstaellning av farmakologiskt vaerdefulla 4-aminofenyletanolaminer med saerskilt beta2-mimetisk och ala1-blockerande verkan
FI63754B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar ftalan
US4360519A (en) Analgesic method using a morpholine compound
JPH10502920A (ja) アリールピペラジンから誘導される新規なピペラジド、それらの製造法、それらの医薬としての使用、およびそれらを含んでなる医薬組成物
IE53016B1 (en) Benzazepines and benzodiazepines
IE921986A1 (en) Fluoroalkoxybenzylamino derivatives of nitrogen containing¹heterocycles
JPH02231486A (ja) 新規β―アドレナリン作動剤
DE2245159A1 (de) Stickstoffhaltige heterocyclische verbindungen
DE69019293T2 (de) Naphthyloxazolidon-Derivate.
Gupta et al. A convenient one pot synthesis of fentanyl
CS258138B2 (en) Method of arylcyclobutylalkylamines production
NZ239267A (en) 3-substituted piperidine derivatives and pharmaceutical compositions
US5852019A (en) Pyrimidinylpyrazole derivatives
EP0558487B1 (en) Piperidine compounds, their preparation and use
US4420480A (en) Hexahydronaphth[1,2-b]-1,4-oxazines
FI77224B (fi) Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara aminopropanolderivat av 2-hydroxi- -fenylpropiofenoner.
HU185133B (en) Process for producing 1-hydroxy-octahydro-benzo-bracket-c-bracket closed-quinolines and derivatives
IE54157B1 (en) Hexahydronaphth (1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
HU185422B (en) Process for producing phenyl-azacycloalkanes
AU736710B2 (en) New indanol compounds, a process for their preparation and pharmaceutical compositions containing them
US3751416A (en) 3-(2-(4-phenyl-1-piperazinyl)-ethyl)indolines
US3830806A (en) Derivatives of 1-phenoxy-3-amino-propan-2-ol
JPS6011901B2 (ja) 新規の脂肪族置換された４−フエニル−ピペリジン
US5541217A (en) 4-arylcyclopenta[c]pyrrole analgesics
AU2001292236B2 (en) 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis